Sort
130,381 grants matching “hiv”
Do Early Maternal Antibodies Facilitate Oral Transmission of HIV in Infants?
$843,374Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · R01 · FY2012 · DE
ULTIMATE
$843,360Reinout Van Crevel · Stichting Radboud Universitair Medisch Centrum I.O. · R01 · FY2022 · AI
Structure and Function of APOBEC Proteins
$843,330Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Southern Asia HIV/AIDS Clinical Trials Unit
$843,314David D. Celentano · Johns Hopkins University · UM1 · FY2013 · AI
HIV-2 latency and its reversal
$843,234Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2025 · AI
HIV-2 latency and its reversal
$843,234Athe M. Tsibris · Brigham And Women'S Hospital · R01 · FY2024 · AI
Efficient and scalable microfluidic gene delivery to hematopoietic stem cells to treat blood diseases
$843,224Sewoon Han · Cellfe Inc. · R44 · FY2023 · HL
Improved delivery of bNAbs for targeting CNS infection in infants
$843,177Jing Wen · University Of California Los Angeles · R01 · FY2024 · NS
INTERNATIONAL TRAINING PROGRAM IN EPIDEMIOLOGY OF AIDS
$843,174Columbia University Health Sciences · D43 · FY2001 · TW
Chlamydial Immunity and Vaccine Development
$843,162Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
INCREASING ACCESS TO QUALITY COMPREHENSTIVE HIV PREVENTION SERVICES FOR MOST-AT-
$843,149Dr. Hector Jalipa · International Medical Corps · U2G · FY2013 · PS
Substance Use and Immunity in HIV+ Adolescents by Systems Biology
$843,141Li Yin · University Of Florida · R01 · FY2014 · DA
The TENDAI study: Task shifting to treat depression and HIV medication nonadherence in low resource settings
$843,138Melanie Amna Abas · King'S College London · R01 · FY2019 · MH
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
$843,131Louis J. Picker · Oregon Health & Science University · R01 · FY2015 · AI
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
$843,126Daniel Kulp · Wistar Institute · R01 · FY2023 · AI
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV
$843,043Catarina E Hioe · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AI
Computer Analysis of Nucleic Acid Structure
$842,930Bruce A. Shapiro · Basic Sciences · Z01 · FY2007 · CA
LpxC inhibitors as a novel class of antibiotics against N. gonorrhoeae
$842,898Pei Zhou · Duke University · R01 · FY2011 · AI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative
$842,860Maxine L Stitzer · Johns Hopkins University · UG1 · FY2015 · DA
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$842,835Loretta Emily Haddy · West Virginia State Dept Hlth/Human Rscs · U62 · FY2014 · PS
Phase II clinical evaluation of Omnitram in neuropathic pain
$842,819Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2016 · DA
STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS
$842,815Guido Silvestri · Emory University · R37 · FY2017 · AI
Mechanisms of SIV suppression by CD8+ lymphocytes
$842,716Guido Silvestri · Emory University · R01 · FY2010 · AI
Tuning Fc-effector functions of HIV-specific antibodies
$842,668Galit Alter · Massachusetts General Hospital · R01 · FY2014 · AI
Role Of Monocytes In AIDS And As Targets For Antiviral Therapy
$842,606Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE